Development of a novel drug which has immunomodulatory properties. Work with Imperial College on analysis of novel nematode oligosaccharides as potential immunogens.
Call to action content
Newsletter
Trim content
Copyright: The Pirbright Institute 2014-2023 | A company limited by guarantee, registered in England no. 559784. The Institute is also a registered charity.
